Παρασκευή, 10 Δεκεμβρίου 2010

The Economic Adjustment Programme for Greece autumn 2010

Regarding pharmaceuticals, the government implements measures yielding savings of at least EUR 2billion relative to the 2010 level, at least EUR 1 billion of which would materialise already in 2011.

−Ensure full implementation of a uniform e-prescribing system, by extending the system currently used by OAEE to all the social security funds providing health insurance;
−Define (through EOF) and publish prescription guidelines for physicians on the basis of international prescription guidelines;
Publish the complete price list for the medicines in the market, using the new pricing  Mechanism.
Apply the negative list of non-reimbursed medicines and the list of over-the-counter  medicines prepared by the EOF.
Finalise the new positive list of reimbursed medicines using the new reference price System
collect the agreed rebate from pharmaceutical companies
−the pharmacy profession, to promote more flexible opening hours and reduce minimum  profit margins (see also measures to modernise the health care system);
Pricing of medicines
Government
−Moves the responsibility of pricing medicines to EOF and all other aspects of
pharmaceutical policy to the Ministry of Health, to rationalise licensing, pricing and
reimbursement systems for medicines;
−Reduce the profit margin of pharmacies on retail prices directly to 15-20 percent, or indirectly by establishing a system of rebates for pharmacies with sales above a  designated threshold. Starting from 2012, pharmacies profit margins should be  calculated as a flat amount or flat fee combined with a small profit margin.????
Και η χαριστική βολή για τις φαρμακαποθήκες
−Reduce the profit margin of wholesale companies distributing pharmaceuticals by at
least one third, from January 2011.
Privatisation and better management of state assets
Government publishes a full inventory of commercial state-owned real-estate assets.
To modernise the health care system Government takes additional measures to promote the use of generic medicines through:
−compulsory doctors' e-prescription by active substance;
−associating a lower cost-sharing rate to generic medicines that have a significantly lower price than the reference price (lower than 60 percent of the reference price) on the basis of the  experience of other EU countries;
setting the maximum price of generics to 60 percent of the branded medicine.


                             ΚΑΛΗ ΧΡΟΝΙΑ

Δεν υπάρχουν σχόλια: